Prime Medicine, Inc.
(NASDAQ: PRME)
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
3.850
+0.240
(+6.65%)
Range
3.580 - 4.080
(13.97%)
Open
3.580
Previous Close
3.610
Bid Price
13.880
Bid Volume
10
Ask Price
14.390
Ask Volume
12
Volume
6,209,670
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
